Bcworld Pharm. Co., Ltd. (200780.KQ) Stock
Bcworld Pharm. Co., Ltd.

Company profile
Bcworld Pharm. reported revenue of 75.80 billion KRW for fiscal year 2025, up 1.3% from fiscal year 2024, and a net loss of 4.90 billion KRW. That is a net profit margin of -6.5% for fiscal year 2025. South Korea was its largest region in fiscal year 2024, with 90% of revenue. Our analysis of its filings shows revenue growing from 75.11 billion KRW in fiscal year 2023 to 75.80 billion KRW in fiscal year 2025, 0.5% a year on average. Bcworld Pharm. reports about 289 full-time employees.
What stands out
- It reported a net loss in each of its last 2 fiscal years (2024 to 2025), after a profit of 2.63 billion KRW in fiscal year 2023.
- Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Bcworld Pharm. Co., Ltd.
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.
Largest shareholders
- Seong-Han Hong20.24 %20.24%
- Young-Gi Hong12.55 %12.55%
- Hyun-ju Hong5.365 %5.37%
- Bcworld Pharm. Co., Ltd.4.56%
- Yong-jae Kim0.2053 %0.21%
Share of the company, as of September 25, 2026
Leadership
- Sung-Han Hong — Chief Executive Officer and President, 68
How much revenue does Bcworld Pharm. make?
Bcworld Pharm. reported 75.80 billion KRW in revenue for fiscal year 2025, up 1.3% from 74.81 billion KRW in fiscal year 2024.
Where does Bcworld Pharm. make most of its revenue?
South Korea: 90% of revenue by region in fiscal year 2024, followed by Overseas (10%).
What companies are similar to Bcworld Pharm.?
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Icure Pharmaceutical Incorporation (175250.KQ), Jin Yang Pharmaceutical Co., Ltd. (007370.KQ), Myungmoon Pharm co.,Ltd (017180.KS), Korea Arlico Pharm Co.,Ltd. (260660.KQ).
Has Bcworld Pharm. made a profit in recent years?
Net income by fiscal year: FY2021, a loss of 1.84 billion KRW; FY2022, 281.30 million KRW; FY2023, 2.63 billion KRW; FY2024, a loss of 4.43 billion KRW; FY2025, a loss of 4.90 billion KRW. It reported a net loss in 3 of these 5 years.
How has Bcworld Pharm.'s revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 62.08 billion KRW; FY2022, 72.70 billion KRW; FY2023, 75.11 billion KRW; FY2024, 74.81 billion KRW; FY2025, 75.80 billion KRW.
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “Bcworld Pharm. Co., Ltd. (200780.KQ)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/200780.KQ